Fundraising Fox

Lauren Mifflin

Investor

Principal of Company Creation at Frazier Life Sciences

Boston

About

Lauren Mifflin joined Frazier Life Sciences in 2023 as a Principal of Company Creation and is CEO/Co-Founder of Counterakt Therapeutics. She previously served as COO of Hillstar Bio, was a venture partner at 82VS (the venture studio of Alloy Therapeutics), and held fellow and operating associate roles at 5AM Ventures, where she worked with the founding teams of Entrada Therapeutics and Nido Biosciences. Earlier she was a health tech investor at Jump Capital and a consultant at Monitor Group/Monitor Deloitte, and she holds a Ph.D. and M.M.Sc. from Harvard, an M.B.A. from the University of Chicago, and undergraduate degrees from the University of Pennsylvania/Wharton.

LinkedIn ↗

Invests in

Biotech

Experience

  1. StealthCoCo-Founder, Board Directorcurrent2025 — present
  2. Counterakt TherapeuticsCo-Founder, CEO, Board Directorcurrent2024 — present
  3. Frazier Life SciencesPrincipal, Company Creationcurrent2025 — present
  4. Frazier Life SciencesVice President, Company Creation2023 — 2025
  5. Hillstar BioCOOcurrent2024 — present
  6. Ypsilon TherapeuticsCo-Founder, Founding CBO, Board Director2022 — 2023
  7. Synkentro TherapeuticsCo-Founder, Board Director2022 — 2023
  8. 82VSVenture Partner2021 — 2023
  9. Nido BiosciencesSenior Scientist, ALS Biology Lead2018 — 2021
  10. 5AM Ventures4:59 Operating Associate2018 — 2020
  11. 5AM VenturesFellow2017 — 2018
  12. Entrada TherapeuticsFellow/Consultant2017 — 2019
  13. Jump CapitalAssociate2014 — 2016Chicago, IL
  14. Monitor Deloitte & Monitor GroupConsultant2011 — 2014New York City, NY
  15. Insight Strategy AdvisorsAnalyst2010New York City, NY
  16. sanofi-aventisPre-Clinical Neuroscience Discovery Research Intern2009Paris Area, France

Education

  1. Harvard UniversityDoctor of Philosophy - PhD, Biological and Biomedical Sciences
  2. Harvard Medical SchoolMaster of Medical Sciences (MMSc), Immunology
  3. The University of Chicago Booth School of BusinessMaster of Business Administration (MBA), Entrepreneurship & Finance
  4. The Wharton SchoolBachelor of Science (BSc) Economics, Concentration in Health Care Management
  5. University of PennsylvaniaBachelor of Arts (BA), Neurobiology

Skills & more

  • Preparing to be a Corporate Director — Harvard Business School Executive Education
  • NACD Accelerate — NACD (National Association of Corporate Directors)

From Lauren's professional profile.

Same school

Also attended Harvard University1,171

Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures

+ 1,165 more

Also attended Harvard Medical School113

Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 107 more

Also attended The Wharton School1,323

Fred WilsonCo-founder & Partner at Union Square VenturesJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General CatalystRebecca JamesInvestor at Index Ventures

+ 1,317 more

Also attended University of Pennsylvania607

Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire VenturesJames KuklinskiInvestor at Spark CapitalKerry KilleenAssociate General Counsel at Revolution

+ 601 more

Shared employers

Also worked at Ypsilon Therapeutics2

Melissa LokugamageSenior Venture Associate at 82VSDongxing ZhaFounder / EIR at 82VS

Also worked at 5AM Ventures20

Anika GuptaInvestor at GV (Google Ventures)Susan LiuInvestment Team at 8VCMira ChaurushiyaManaging Director at Westlake Village BioPartnersLucy LiuPrincipal at Longwood FundKush M ParmarManaging Partner at 5AM VenturesAndy SchwabManaging Partner at 5AM Ventures

+ 14 more

Also worked at Entrada Therapeutics6

Kush M ParmarManaging Partner at 5AM VenturesMax FarinaPrincipal at 5AM VenturesJackson SaundersInvestor at Cybernetix VenturesDr Arjun GoyalInvestment committee member at Tin Alley VenturesJason RuthPartner at MRL Ventures FundArjun GoyalManaging Director at Vida Ventures

Also worked at Monitor Deloitte & Monitor Group65

Erica WuInvestment Director at Intel CapitalCandice FaktorFounder, CEO, speaker, and investor focused on unlocking human potential in the age of AIParth DesaiPartner at Flare Capital PartnersAaron SamuelsFounder at Collide CapitalAravind RatnamChief Strategy Office, Q-Ctrl at SeafundDave BoyceDirector at Mercato Partners

+ 59 more

Deals · 1

Aldebaran TherapeuticsBoard seat

via Frazier Life Sciences · filed Mar 2022 · $1.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Frazier Life Sciences

Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences